40,000 required, very interesting but where? The Company estimates that 40,000 VMS+3.0 units would be required based on standard-of-care guidelines to effectively diagnose, monitor and manage the health of patients with congenital heart disease, pulmonary hypertension and those suffering cardiotoxicity due to chemotherapy.
Is that World Wide, North America, US, surely not Canada? Dr Adams thought only 80-100 needed for a buyout to be possible. 40000 required is great number but unclear where that entails.